Brannagan, T. H., Wang, A. K., Coelho, T., Waddington Cruz, M., Polydefkis, M. J., Dyck, P. J., . . . Gertz, M. (2020). Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: A 2‐year update from the open‐label extension of the NEURO‐TTR trial. Eur J Neurol.
Chicago-tyylinen lähdeviittausBrannagan, T. H., et al. "Early Data On Long‐term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis: A 2‐year Update From the Open‐label Extension of the NEURO‐TTR Trial." Eur J Neurol 2020.
MLA-viiteBrannagan, T. H., et al. "Early Data On Long‐term Efficacy and Safety of Inotersen in Patients With Hereditary Transthyretin Amyloidosis: A 2‐year Update From the Open‐label Extension of the NEURO‐TTR Trial." Eur J Neurol 2020.